Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence

Despite recent advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year overall survival of only 10%. Since either at or within a few months of diagnosis, most patients with PDAC will present with metastatic disease, a more individualized approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Adekolujo, Orimisan Samuel, Wahab, Ahsan, Akanbi, Maxwell Oluwole, Oyasiji, Tolutope, Hrinczenko, Borys, Alese, Olatunji Boladale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395259/
https://www.ncbi.nlm.nih.gov/pubmed/37526431
http://dx.doi.org/10.1080/15384047.2023.2198479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395259/
https://www.ncbi.nlm.nih.gov/pubmed/37526431
http://dx.doi.org/10.1080/15384047.2023.2198479

Ejemplares similares